Opioid Toxicity Crisis: A View Into the Challenges and Opportunities Ahead—A Narrative Review

Abstract

This narrative review examines the escalating opioid crisis, particularly focusing on the role of fentanyl and its analogues in opioid-related overdose deaths in the United States and Asia. Data indicates a significant increase in fatalities linked to opioid misuse, with fentanyl being 50–100 times more potent than morphine, and a staggering 82.3% of opioid-related deaths in 2020 were attributable to overdoses. The article analyzes contributing factors to opioid toxicity, including dosage, tolerance, combination with other substances, administration routes, individual physiological responses, and polydrug use. It highlights the epidemiology of opioid toxicity across the USA and various Asian countries, identifying similarities and differences in prevalence, risk factors, and governmental responses. The review discusses the efficacy of current prevention strategies, such as the Prescription Drug Monitoring Programs (PDMPs), opioid substitution therapy (OST), and harm reduction initiatives, while emphasizing the need for improved public education and awareness. Furthermore, it addresses the challenges in managing opioid toxicity, such as rapid onset of action, risk of co-ingestion, and the importance of naloxone administration. The article advocates for a coordinated, multi-faceted approach that includes data sharing, policy harmonization, international collaboration, and technological innovations, particularly artificial intelligence, to mitigate the opioid crisis and enhance patient safety. Ultimately, it underscores the necessity for a balanced approach to opioid regulation that considers both legitimate medical use and the complexities of misuse and addiction.

Introduction

Opioids are strong pain-relieving medications that can lead to evident physical dependency and craving. The CDC (Center for Disease Control) has stated a triphasic crisis in the USA, with opioids causing deaths in the 1990s, 2010 and 2013, with fentanyl accounting for the majority of overdose deaths in 2020. ¹ About 82.3% of deaths remained associated with opioid overdose cases. ² Most overdose-caused deaths remained related to fentanyl and its equivalents, such as carfentanyl, furanyl fentanyl, acetyl fentanyl, 4-fluoroisobutyryl fentanyl (or para-fluoroisobutyryl fentanyl), then cyclopropyl fentanyl. ³

The misapplication of carfentanyl in humans, formerly permitted for strict use in animals, has led to an astounding jump up to 45% of overdose-related deaths due to misuse of fentanyl and its analogues, organized with tramadol among 2016 and 2017.^{3, 4} The use of fentanyl unlawfully by illegal drug producers has further compounded the condition due to widespread use of over-the-counter or nonprescription opioids. ⁵ The Drug Enforcement Administration (DEA) promotes for more state-of-the-art advanced technology for the recognition of non-pharmaceutical fentanyl (NPF) in pain medication drug combinations.^{6, 7}

Methods

Literature Search

The literature exploration for writing this narrative review has been completed using literature exploration engines such as Google Scholar, PubMed, and Scopus. Related articles were searched, and at first, the titles and abstracts of the articles were screened. Thereafter, articles related to opioid overdose deaths have been chosen. For running the search, keywords such as opioids, fentanyl, opioid analogues, management strategies, and overdose have been used. Articles which focused on opioid abuse, overdose crisis, opioid management, opioid substitution therapy (OST), harm reduction programs, and governmental strategies on opioid abuse mitigation were included in the search. Around 104 relevant articles have been shortlisted for drafting this narrative review article.

Epidemiology of Opioid Toxicity in the USA and Asia

It is a serious concern for the world. In the USA, about 2.1 million people are impacted by the opioid crisis, while globally, around 16 million people have been adversely impacted. ⁸ Opioid use disorders in the USA, defined by the American Psychiatric Association DSM-5, involve a strong urge to abuse opioids, leading to dependence and addiction. ⁹

In Canada, opioid abuse became a big problem, with opioids being the 10 most common substances detected by Canada’s Drug Analysis Service (DAS).^{10, 11} In Canada, since the 1980s, there has been a growing rate in sales of prescription opioid medication to patients, ranking second after the USA in terms of prescription opioids. ¹² From 2016 and 2017, states such as West Virginia, Ohio, New Hampshire, Pennsylvania, then the District of Columbia documented the peak mortality rates in terms of drug overdose-related deaths.^{13, 14}

Asian nations represent one of the key cases of the world’s unlawful opioid misuse, with India unaided accountancy for the world’s 1/3rd part of the opioid ill-treating populace. ¹⁵ Bangkok fentanyl was traded as heroin, on behalf of a major threat. ¹⁶

This write-up compares opioid toxicity epidemiology in the USA and Asian countries, explores prevalence, use designs, risk factors, and overdose-related morbidity and mortality.

Factors Contribute to Opioid Toxicity

Opioid toxicity, activated by extreme or misused opioid drugs, is prejudiced by numerous aspects, which are critical for stopping and handling contrary actions. Some important features are

Dose and potency: The severity of opioid toxicity is typically determined by the quantity and efficiency of the drug consumed, with high quantities increasing the risk of overdose and toxicity.^{17, 18} Superabundance of opioids is due to additional unbarred inducement of the opiate pathway. This can lead to death due to problems such as failure of the nervous system and respiratory apparatus.^19–21

Tolerance and sensitivity: Chronic opioid use can lead to tolerance, increasing sensitivity to opioid effects and toxicity. Morphine, the most commonly used pain medicine, has been related to amplified adverse effects.^{22, 23}

Combination with other substances: Collaboration of opioids with benzodiazepines or alcohol, or other CNS depressant substances, is possible. Uniting opioids with these constituents can potentiate their properties, leading to respiratory depression and overdose.

Features inducing opioid usage comprise combination with other substances, direction of route, individual factors, and formulation. Combining opioids can lead to respiratory depression and overdose, as seen in the USA.^{24, 25}

1. Route of administration: The administration method of opioids, including intravenous or intranasal use, can significantly impact their onset, intensity, and duration of action, increasing the risk of toxicity. ²⁶

2. Individual factors such as age, weight, liver and kidney function, and pre-existing medical conditions can influence an individual’s response to opioids, potentially increasing toxicity risk.

3. Opiod Formulation: Long-acting opioids require less frequent dosing, better pain management, and reduced risk of overdose and adverse effects.^27–30

4. Accidental ingestion: Opioid medications by children, especially when kept at home, are a cause of accidental toxicity. ³¹ A study of 960 medical case reports from 12 pediatric hospitals found that over half of adverse drug events were caused by opioid use.^{32, 33}

5. Drug Interactions between opioids and other medications pose a significant risk due to their potential to affect metabolism, elevate opioid levels, and impact drug transport, absorption, and cytochrome P-450 enzymes.^{34, 35}

6. Polydrug use, where individuals combine multiple substances for recreational purposes, can increase the risk of opioid toxicity significantly.^{36, 37} In France, 67% of patients had a history of benzodiazepine use in their life, while in Spain, at least 45% were regularly taking benzodiazepines.^38–42

7. Lack of attentiveness about opioid toxicity, signs of overdose, and the importance of seeking prompt medical attention can postpone the treatment and worsen the illness. ⁴³ A study by Binswanger in the USA found some blocks, counting nonappearance of awareness about opioid overdose, ⁴⁴ concerns about legal liability, ⁴⁵ and nonappearance of information about the use of naloxone. ⁴⁶

8. Illicit drugs and contaminants can also surge the risk of toxicity in cases of opioid usage. Research on the general population showed that in the USA, there had been at least 90% of opioid usage had occurred.^47–50 These persons used more than two other materials along with opioids within the same year, and another 25% had used at least two ingredients while having opioid use disorder. ⁵¹

Averting opioid toxicity requires accountable prescribing, patient education, awareness of misuse risks, and access to addiction treatment and naloxone, a medication that reverses opioid overdoses.

Prescription Opioids and Opioid Analogues

Prescription opioids and opioid analogues are both types of opioid drugs, but have some key changes in their origins and legal status:

Prescription Opioids

Prescription opioids are a class of medicines that are lawfully prescribed by healthcare specialists to manage pain. These drugs are resulting from opium or synthesized in laboratories to mimic the effects of natural opiates. Common prescription opioids include:

Codeine: A comparatively mild opioid frequently used in combination with added medications to treat pain or suppress coughing.

Morphine: A potent opioid used in hospitals for mitigation of intermediate to severe grade pain.

Oxycodone: A strong opioid available to handle reasonable to severe pain and is reachable in both at once release and extended-release forms.

Hydrocodone: Hydrocodone is typically used in combination with NSAIDS, such as Ibuprofen or Acetaminophen, to alleviate modest to critical pain.

Hydromorphone: A very strong opioid used in some situations to handle critical pain.

Fentanyl: An enormously potent synthetic opioid used for managing severe pain, often in the form of coverings or lozenges.

Prescription opioids can be effective in treating pain when used appropriately beneath the guidance of a healthcare professional. However, they also carry a risk of dependence and overdose if misused or taken deprived of a prescription.

Opioid Analogues

Opioids, together with prescription and synthetic, can efficiently treat pain under healthcare guidance, but misuse or overdose can lead to misuse, requirement, and mimic the effects of natural opioids like morphine or heroin. ⁵²

Fentanyl, a strong painkiller, is regularly prescribed in medical practice for severe pain,^{53, 54} predominantly in cancer patients, and its short-acting analogues, alfentanil, sufentanil, and remifentanil, are frequently used in anesthesia events.^{55, 56}

Opioids should be used carefully and according to medical guidance to avoid abuse, addiction, and overdose. Seeking qualified help is crucial for recovery.

Opioid Regulation and Strategies

The opioid epidemic in the USA is inclined by cultural attitudes, healthcare systems, drug abuse rates, and political considerations, resulting in state-specific laws then policies. ⁵⁷ such as monitoring the prescription drugs, ⁵⁸ management of naloxone dispersal mechanisms,^{59, 60} and remark of pain treatment centers.^61–63

Common Aspects of Opioid Regulation and Policies

Prescription regulations, controlled substance scheduling, and opioid overdose prescription: Most countries regulate opioid prescription and dispersal, demanding that health care workers follow particular strategies. In 2015, the USA issued an attention cautionary about fentanyl and its connections. ⁶⁴ In 1996, Chinese policymakers applied legal restrictions on fentanyl and registered it in the collection of narcotic resources. ⁶⁵

Controlled substance scheduling contains needful primary care workers to form a reliable team capable of responding to opioid crises and decisive the most effective naloxone administration method.

Opioid Overdose Prescription

In the United States, 50,000 people remained experts between 1996 and 2010 under the OEND program, saving about 10,000 lives in cases of overdose through the management of naloxone.^66–68

China is applying numerous programs to prevent opioid overdose deaths, with identification and inhibition, detoxification, and peer education training. ⁶⁹ Naloxone kits are used in hospitals and emergency ambulance amenities, with the first community-based organization of naloxone launched in 2008 on a restricted scale. ⁷⁰

Prescription Drug Monitoring Programs (PDMPs) are real pools of electronic accounts that serve as a method of prescribing and providing controlled substances, including opioids.^{71, 72}

Opioid Substitution Therapy

OST reduces HIV transmission risk and health hazards in parental abusers, falling abscesses, contagions, septicemia, and endocarditis, purifying life quality and health.^73–75

Harm minimization programs and Drug misuse control programs aim to mitigate harmful effects, deprived of strict bans, counting harmless needle sharing, checked consumption sites, education on harmless drug use means, and bloodborne contagion testing. ⁷⁶ , The CDC advocates for cautious opioid use in chronic pain patients to stop overdoses and long-term side effects, and needful initial non-opioid use beforehand transitioning to opioids.^77–79

Criminalization and Law Enforcement are additional vital aspects of speaking opioid toxicity. Some nations have required strict laws and penalties on owning and use of drugs, asserting them as criminal offenses. ⁸⁰ For example, Singapore has a zero-tolerance policy to illicit drug transporting and prescribes the death penalty to persons and imprisoned with charges of unlawful drug trafficking. Other nations such as Myanmar, Laos, Thailand, Brunei, and Vietnam have alike punitive actions in place.^{81, 82}

Public education and awareness are significant strategies to minimize the growth rates of opioid misuse and addiction. Plans such as new policy development, population education, and social campaigns can be very effective^{83, 84} in spreading alertness about the dangers linked with opioid abuse and minimizing the problem of stigmatization of opioid misusers in society.^{85, 86} It is critical to strike a stability among the legitimate medical use of opioid medications and the complexities of opioid misuse and addiction.^87–89

Challenges in addressing opioid toxicity include rapid onset of action, risk of co-ingestion, administration of naloxone, prescribing guidelines and practices, and long-term management. In the USA, irrational prescription practices have been attributed as a major contributor to the opioid crisis.^90–92 The CDC guidelines require healthcare givers to prescribe opioid medications judiciously and keep them reserved for management of severe intractable pain in cancer patients and avoid use as far as possible in patients with chronic pain due to non-cancer etiology.^{93, 94}

Long-term opioid management is crucial, addressing root causes and providing follow-up care. ⁹⁵ In China, trained human resources are desired for methadone rehabilitation clinics, though in the USA, therapy is essential.^{96, 97}

The opioid crisis demands considerable government care and financial assistance for suitable treatment and upkeep programs, including increased subsidies for Methadone Maintenance Therapy clinics in China. ⁹⁸

Treatment strategies include developing a model across nations and states, identifying cases of opioid toxicity, and treating overdose with prompt administration of naloxone. ⁹⁹ Naloxone is used as an initial defense in prehospital situations, reversing nervous system and respiratory depression, while Medication Assisted Treatment (MAT) is implemented, involving methadone and Buprenorphine for maintenance therapy. ¹⁰⁰

Naltrexone, its extended-release form, has been available for deep muscle injection since 2017 and is active in opioid maintenance therapy. ¹⁰¹ Buprenorphine, in an implantable method, was permitted by the US FDA in 2016 and is now obtainable as Probuphine. ¹⁰²

Prevention and Education Initiatives

1. Education and awareness agendas are vital for raising awareness about the health hazards and risks of opioid misuse, including public awareness in schools and health care provider-moderated meetings on pain minimization alternatives.^{103, 104}

2. Enhance treatment accessibility by providing validation-based procedures like MAT and making counseling and behavioral treatment centers easily reachable in hospitals, clinics, and mobile opioid treatment centers.

The global opioid crisis, aggravated by synthetic opioids and misuse in pain management, dictates coordination among agencies, organizations, and governmental organizations to develop tailored plans and policies. This contains data distribution, policy coordination, and supply chain rules. Association among international organizations like the World Health Organization, UNODC, and Interpol is vital.

Artificial Intelligence-aided support and management programs

Emerging predictive analysis algorithms using demographic records, medical records, and prescription data.

Prescription monitoring schemes driven by AI can track patients on opioid medications and send alerts to physicians about overdose or misuse.

Smart wearable AI-enabled devices used for improved tracking and monitoring of opioid patients.

AI for early intervention events using virtual assistants and chatbots, providing patients with data about pain management and informed policymaking.

AI can also improve treatment by providing better data about patients based on patient records and side effects.

Genetic research using AI to identify an individual’s genetic predisposition toward opioid addiction.

Data exploration based on patterns can help health agencies and organizations understand the pattern of opioid abuse and toxicity in society, enabling effective intervention measures and resource allocation.

Conclusion

Opioid abuse and toxicity are a major challenge in today’s world. The development of synthetic opioids and their application in pain management, followed by their irrational use and prescription, has caused a serious health crisis. There is a need for systematic collaboration among governments and organizations to develop policies and regulations aimed at the effective control of opioid production, marketing, distribution, and prescription. There is a need for educating and training healthcare givers about opioid medications.

There is a need for providing training to healthcare personnel on opioid medication, pain management guidelines and safe opioid prescription practice. Robust mechanisms to monitor opioid dependent patients, opioid addicts, and illicit users should be developed through cooperation of the healthcare sector, government and social organizations, Artificial intelligence should also be used to ensure patient support, patient education, proper surveillance and monitoring and as well as data mining to continuously monitor the epidemiology and magnitude of opioid problem in society. This will enable organization and governmental bodies to create opioid reduction and opioid abuse, and toxicity management policies based on the specific requirements of the patient and healthcare community.